Sandler Alan B.
- SEC CIK
- 0001835966
In the past year, 2 open-market sale filings worth $1.34M and no purchases.
Current role at each company
- RVMD Revolution Medicines, Inc.Chief Development Officeras of Oct 1, 2026
- ALXO Alx Oncology Holdings IncDirectoras of Jan 21, 2026
- Elevation Oncology, Inc.Directoras of Jul 24, 2025
- MRTX Mirati Therapeutics, Inc.Chief Medical Officeras of Jan 23, 2024
- ZLAB Zai Lab LtdHead of Global Dev., Oncologyas of Jun 27, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.34M
- 2 filings
- Net
- −$1.34M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sandler Alan B. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RVMD Revolution Medicines, Inc.
Chief Development Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 (view filing)6:06 PM ET | Sep 16 | 2 days | Sandler Alan B.Chief Development Officer | SSale | −341 | $199.24 | −$67.9K | −0.6%52.9K after | 2 lots10b5-1 |
| Oct 1, 2026 (view filing)6:00 PM ET | Sep 29 | 2 days | Sandler Alan B.Chief Development Officer | SSale | −6.31K | $202.14 | −$1.28M | −10.7%52.6K after | 5 lots10b5-1 |